newsfilter
← Latest News
PR Newswire·

Sorrento Therapeutics, Inc. Receives Court Approval for "First Day" Employee Wages and Cash Management Motions

SAN DIEGO, Feb. 16, 2023 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ:SRNE, ", Sorrento", )), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat cancer, intractable